Aaron Green Sells 61,555 Shares of OneMedNet (NASDAQ:ONMD) Stock

OneMedNet Corporation (NASDAQ:ONMD) CEO Aaron Green sold 61,555 shares of the stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $1.20, for a total value of $73,866.00. Following the completion of the sale, the chief executive officer owned 1,804,103 shares in the company, valued at approximately $2,164,923.60. The trade was a 3.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Aaron Green also recently made the following trade(s):

• On Wednesday, October 22nd, Aaron Green sold 64,767 shares of OneMedNet stock. The stock was sold at an average price of $2.23, for a total transaction of $144,430.41.

OneMedNet Stock Performance

NASDAQ:ONMD traded down $0.11 during trading hours on Tuesday, hitting $1.29. The company’s stock had a trading volume of 328,793 shares, compared to its average volume of 2,257,584. The company has a market capitalization of $65.80 million, a PE ratio of -25.80 and a beta of 1.10. The business’s 50-day moving average is $1.73 and its two-hundred day moving average is $1.14. OneMedNet Corporation has a 52-week low of $0.30 and a 52-week high of $4.22.

OneMedNet (NASDAQ:ONMD) last issued its quarterly earnings data on Friday, November 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $0.18 million during the quarter.

Institutional Trading of OneMedNet

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ONMD. Correct Capital Wealth Management bought a new stake in shares of OneMedNet during the third quarter valued at approximately $4,910,000. Ashton Thomas Private Wealth LLC purchased a new position in shares of OneMedNet during the third quarter worth approximately $25,000. Finally, Exencial Wealth Advisors LLC lifted its position in shares of OneMedNet by 141.3% during the third quarter. Exencial Wealth Advisors LLC now owns 3,599,460 shares of the company’s stock valued at $3,923,000 after buying an additional 2,107,598 shares during the last quarter. Hedge funds and other institutional investors own 0.95% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have commented on ONMD. Weiss Ratings restated a “sell (d-)” rating on shares of OneMedNet in a research note on Tuesday, October 14th. Wall Street Zen upgraded OneMedNet to a “hold” rating in a report on Friday, September 26th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

About OneMedNet

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.